Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics

Phytother Res. 2022 Apr;36(4):1523-1544. doi: 10.1002/ptr.7395. Epub 2022 Jan 27.

Abstract

The nervous system is one of the most complex physiological systems, and central nervous system diseases (CNSDs) are serious diseases that affect human health. Ginseng (Panax L.), the root of Panax species, are famous Chinese herbs that have been used for various diseases in China, Japan, and Korea since ancient times, and remain a popular natural medicine used worldwide in modern times. Ginsenosides are the main active components of ginseng, and increasing evidence has demonstrated that ginsenosides can prevent CNSDs, including neurodegenerative diseases, memory and cognitive impairment, cerebral ischemia injury, depression, brain glioma, multiple sclerosis, which has been confirmed in numerous studies. Therefore, this review summarizes the potential pathways by which ginsenosides affect the pathogenesis of CNSDs mainly including antioxidant effects, anti-inflammatory effects, anti-apoptotic effects, and nerve protection, which provides novel ideas for the treatment of CNSDs.

Keywords: central nervous system diseases; ginsenosides; mechanisms; pharmacological actions; therapeutics.

Publication types

  • Review

MeSH terms

  • Central Nervous System Diseases* / drug therapy
  • Ginsenosides* / pharmacology
  • Ginsenosides* / therapeutic use
  • Humans
  • Neurodegenerative Diseases* / drug therapy
  • Panax*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Ginsenosides
  • Plant Extracts